From the CEO
Arrowhead CEO Provides Update on Company Strategy and Operations
PASADENA, Calif. — Arrowhead Research Corporation’s (NASDAQ: ARWR) (“the Company”) President and Chief Executive Officer today issued the following letter to the Company’s shareholders: more...
February 18, 2009
Arrowhead CEO Comments on Recent Nasdaq Letter
PASADENA, Calif. — Arrowhead Research Corporation’s (NASDAQ: ARWR) (“the Company”) President and Chief Executive Officer today issued the open letter to the Company’s shareholders. more...
November 19, 2008
Arrowhead CEO Provides Update on Tego Biosciences Corporation
PASADENA, Calif. — Arrowhead Research Corporation’s (NASDAQ: ARWR) Chief Executive Officer announces an update to stockholders on its wholly owned subsidiary, Tego Biosciences Corporation. more...
November 12, 2008
Arrowhead CEO Provides Update on Nanotope, Inc.
PASADENA, Calif. — Arrowhead Research Corporation’s (NASDAQ: ARWR) Chief Executive Officer announces an update to stockholders on Nanotope, Inc. more...
November 4, 2008
Arrowhead CEO Provides Update on Majority Owned Subsidiary Unidym, Inc.
PASADENA, Calif.—Arrowhead Research Corporation’s (NASDAQ: ARWR) Chief Executive Officer announces an update to stockholders on its majority owned subsidiary, Unidym. more...
October 28, 2008
Arrowhead CEO Provides Update on Wholly Owned Subsidiary Agonn Systems, Inc.
PASADENA, Calif.—Arrowhead Research Corporation’s (NASDAQ: ARWR) Chief Executive Officer announces an update to stockholders on its wholly owned subsidiary, Agonn Systems Corporation. more...
October 21, 2008
Arrowhead CEO Provides Update on Majority Owned Subsidiary Calando Pharmaceuticals Inc.
Arrowhead Research Corporation (NASDAQ: ARWR) announced today that the Company's CEO has provided an update letter to stockholders on its majority owned subsidiary, Calando Pharmaceuticals. more...
October 14, 2008
Arrowhead CEO Updates Stockholders
Pasadena, California — Arrowhead Research Corporation (NASDAQ: ARWR) announced today that the Company's CEO has provided an update letter to stockholders. more...